Search

Your search keyword '"Vanderstichele, Adriaan"' showing total 164 results

Search Constraints

Start Over You searched for: Author "Vanderstichele, Adriaan" Remove constraint Author: "Vanderstichele, Adriaan" Search Limiters Full Text Remove constraint Search Limiters: Full Text
164 results on '"Vanderstichele, Adriaan"'

Search Results

1. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis

2. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

3. Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study

4. Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast

5. Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer

6. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

7. Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis

8. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

9. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

10. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes

12. Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan

13. Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

16. Abstract P2-11-20: Challenging the current 1-10% cut-off for defining Estrogen Receptor Low Positive grade 2-3 Estrogen Receptor positive, Human Epidermal growth factor Receptor 2 negative early breast cancer

17. Systematic study of tissue factor expression in solid tumors

18. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets

19. Abstract A008: TP53 field defects in uterine fluid are associated with ovarian cancer risk

20. Abstract PR005: TP53 field defects in uterine fluid are associated with ovarian cancer risk

21. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer

22. Systematic study of tissue factor expression in solid tumors.

23. Additional file 3 of High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification

24. Additional file 6 of High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification

25. Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.

26. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers.

27. Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines

28. Abstract P5-06-28: Optimization and validation of PIK3CA mutation detection with droplet digital PCR in liquid biopsies of patients with metastatic breast cancer

29. miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study

30. Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer

31. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

32. miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study.

33. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

34. Identification of nine new susceptibility loci for endometrial cancer

35. Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer

36. Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses

37. Identification of nine new susceptibility loci for endometrial cancer.

38. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.

39. Genetic overlap between endometriosis and endometrial cancer: Evidence from cross-disease genetic correlation and GWAS meta-analyses

40. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

41. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

42. Quality-of-life analysis in the randomized phase II CLIO trial comparing olaparib with standard chemotherapy in platinum-resistant recurrent ovarian cancer

43. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

44. A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

45. Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer

46. Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses

47. Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer

48. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

49. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

50. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

Catalog

Books, media, physical & digital resources